70 Years of Levothyroxine / edited by George J. Kahaly
Contributor(s): Kahaly, George J., editor literario
Material type:
E-bookPublisher: Cham : Springer International Publishing, 2021Edition: 1st edition 2021.Description: 1 recurso en línea (XVII, 129 páginas) : 37 ilustraciones, 34 ilustraciones a color.ISBN: 9783030632779.Subject: Tiroides -- Enfermedades -- Tratamiento
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC655 2021 EB (Browse shelf(Opens below)) | Acceso electrónico | eBook.14102070 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| RC655 2020 EB Hypoparathyroidism. A Clinical Casebook | RC655 2020 EB Atlas of Parathyroid Surgery | RC655 2021 EB Thyroid, Obesity and Metabolism : Exploring Links Between Thyroid Function, Obesity, Metabolism and Lifestyle | RC655 2021 EB 70 Years of Levothyroxine | RC655 2022 EB Parathyroid Gland Disorders : Controversies and Debates | RC655 2023 EB Controversies in Thyroid Nodules and Differentiated Thyroid Cancer : A Case-Based Approach | RC655 .H97 2015 EB Hypoparathyroidism |
History Of Levothyroxine -- Pharmacokinetics Of Levothyroxine -- Pharmacodynamics Of Levothyroxine -- Levothyroxine In Pregnancy -- Levothyroxine In Children -- Levothyroxine In The Elderly -- Levothyroxine And Heart -- Levothyroxine And Bone -- Levothyroxine And Cancer -- Potential Adverse Reactions Of Levothyroxine.
Open Access
This open access book presents the history, pharmacokinetics and pharmacodynamics of levothyroxine, discussing its role in the thyroid pathophysiology of patients of various ages and during pregnancy. It also describes the influence of levothyroxine on heart, bone and in cancer. When it was first synthesized in 1949, levothyroxine represented a significant advance in the treatment of hypothyroidism, providing a safe and effective treatment option for millions of hypothyroid patients around the globe. This synthetic form of thyroxine is now one of the most prescribed drugs in the world. Levothyroxine was first introduced by Merck KGaA,Darmstadt, Germany, in 1972, and since then the company has remained actively engaged in research on this mainstay of hypothyroidism treatment. This book is intended for healthcare professionals.
There are no comments on this title.